Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 99474 · Class II · New York Blood Center Inc
Key facts
| Event ID | 99474 |
|---|---|
| Recall numbers | B-0185-2026 |
| Recalling firm | New York Blood Center Inc |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cells, Leukocytes Reduced, collected from a donor who was previously deferred for testing repeatedly reactive for the antibody to hepatitis C virus, was distributed. |
| Initiation date | Jul 16, 2026 |
| Report date | Aug 19, 2026 |
| Termination date | Aug 13, 2026 |
| City | St. Paul |
| State | MN |
| Country | United States |
| FEI number | 2170665 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: